Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 9/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 7/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24239105 | 0.97 | ALOX5 (0.37) | ALOX5S1PR5S1PR4CYP1A1CYP1B1 | |
| SCHEMBL21149237 | 0.88 | S1PR5 (0.38) | ALOX5S1PR5S1PR4CYP1A2PIM1 | |
| SCHEMBL26448301 | 0.86 | S1PR5 (0.36) | ALOX5S1PR5S1PR4CYP1A1CYP1B1 | |
| SCHEMBL21149207 | 0.86 | S1PR5 (0.38) | ALOX5S1PR5S1PR4CYP1A2PIM1 | |
| SCHEMBL21148232 | 0.86 | S1PR5 (0.40) | ALOX5S1PR5S1PR4CYP1A2PIM1 | |
| SCHEMBL24266824 | 0.86 | S1PR5 (0.40) | ALOX5S1PR5S1PR4CYP1A2PIM1 | |
| SCHEMBL22247879 | 0.85 | ALOX5 (0.48) | ALOX5S1PR5S1PR4PRKDC | |
| SCHEMBL23511922 | 0.85 | S1PR5 (0.36) | ALOX5S1PR5S1PR4CYP1A2PIM1 | |
| SCHEMBL24193006 | 0.85 | CYP1A1 (0.42) | ALOX5S1PR5S1PR4CYP1A1CYP1B1 | |
| SCHEMBL27252802 | 0.85 | S1PR5 (0.42) | ALOX5S1PR5S1PR4CYP1A2PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-20220037594-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | ALOX5 624/4885S1PR5 4709/4885S1PR4 4471/4885 |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | ALOX5 794/4885S1PR5 4681/4885S1PR4 4351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.